These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20693817)

  • 41. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
    Jonas JB; Kreissig I; Spandau UH; Harder B
    Am J Ophthalmol; 2006 Mar; 141(3):579-80. PubMed ID: 16490517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
    Wykrota AA; Abdin AD; Munteanu C; Löw U; Seitz B
    Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3569-3579. PubMed ID: 37432451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.
    van Kooij B; Rothova A; de Vries P
    Ocul Immunol Inflamm; 2006 Apr; 14(2):73-85. PubMed ID: 16597536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of intravitreal triamcinolone acetonide injection with and without preservative.
    Maia M; Farah ME; Belfort RN; Penha FM; Lima Filho AA; Aggio FB; Belfort R
    Br J Ophthalmol; 2007 Sep; 91(9):1122-4. PubMed ID: 17383993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema.
    Sevim MS; Sanisoglu H; Turkyilmaz K
    Curr Eye Res; 2012 Dec; 37(12):1165-70. PubMed ID: 22928501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Er H; Yilmaz H
    Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
    Rahimi M; Shahrzad SS; Banifatemi M
    Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Noninfectious hypopion after intravitreal triamcinolone acetonide injection for central retinal vein occlusion: a case report.
    Chiu YT; Tsai YY; Lin JM
    Kaohsiung J Med Sci; 2005 Oct; 21(10):466-9. PubMed ID: 16302450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
    Williamson TH; O'Donnell A
    Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
    Jonas JB; Kreissig I; Degenring RF
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term complications of intravitreal injections of triamcinolone and bevacizumab.
    Jonas JB; Spandau UH; Schlichtenbrede F
    Eye (Lond); 2008 Apr; 22(4):590-1. PubMed ID: 18292795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide].
    Le Moigne O; Duncombe A; Portmann A; Muraine M; Genevois O
    J Fr Ophtalmol; 2012 Nov; 35(9):700-4. PubMed ID: 22925843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
    Taban M; Singh RP; Chung JY; Lowder CY; Perez VL; Kaiser PK
    Am J Ophthalmol; 2007 Jul; 144(1):50-54. PubMed ID: 17601427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
    Paccola L; Costa RA; Folgosa MS; Barbosa JC; Scott IU; Jorge R
    Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study.
    Koutsandrea C; Moschos MM; Brouzas D; Loukianou E; Apostolopoulos M; Moschos M
    Retina; 2007 Feb; 27(2):159-64. PubMed ID: 17290196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    J Glaucoma; 2005 Feb; 14(1):90; author reply 90. PubMed ID: 15650615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.